CDK2 Inhibition and Eradication of Aneuploid Cancers: Promise Meets Resistance.

Okpechi SC, Chen Z, Tyutyunyk-Massey L, Alfaro Y, Liu X, Dmitrovsky E

Open source

DOI
10.1158/1535-7163.mct-26-0181
Published
2026 Sep 2
Container
Molecular cancer therapeutics
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1158/1535-7163.mct-26-0181,
  title = {CDK2 Inhibition and Eradication of Aneuploid Cancers: Promise Meets Resistance.},
  author = {Okpechi SC and Chen Z and Tyutyunyk-Massey L and Alfaro Y and Liu X and Dmitrovsky E},
  year = {2026},
  journal = {Molecular cancer therapeutics},
  doi = {10.1158/1535-7163.mct-26-0181},
  url = {https://doi.org/10.1158/1535-7163.mct-26-0181}
}

RIS

TY  - JOUR
TI  - CDK2 Inhibition and Eradication of Aneuploid Cancers: Promise Meets Resistance.
AU  - Okpechi SC
AU  - Chen Z
AU  - Tyutyunyk-Massey L
AU  - Alfaro Y
AU  - Liu X
AU  - Dmitrovsky E
PY  - 2026
JO  - Molecular cancer therapeutics
DO  - 10.1158/1535-7163.mct-26-0181
UR  - https://doi.org/10.1158/1535-7163.mct-26-0181
ER  - 

APA

SC, O., Z, C., L, T., Y, A., X, L., & E, D. (2026). CDK2 Inhibition and Eradication of Aneuploid Cancers: Promise Meets Resistance.. Molecular cancer therapeutics. https://doi.org/10.1158/1535-7163.mct-26-0181

Source records